Literature DB >> 17890421

Drug development for treatment of cardiac arrhythmias: targeting the gap junctions.

Andrew L Wit1, Heather S Duffy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17890421     DOI： 10.1152/ajpheart.01031.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN： 0363-6135            Impact factor:   4.733


× No keyword cloud information.
  7 in total

1.  A peptide mimetic of the connexin43 carboxyl terminus reduces gap junction remodeling and induced arrhythmia following ventricular injury.

Authors:  Michael P O'Quinn; Joseph A Palatinus; Brett S Harris; Kenneth W Hewett; Robert G Gourdie
Journal:  Circ Res       Date:  2011-01-27       Impact factor: 17.367

Review 2.  Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.

Authors:  Stefan Dhein; Anja Hagen; Joanna Jozwiak; Anna Dietze; Jens Garbade; Markus Barten; Martin Kostelka; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-27       Impact factor: 3.000

3.  Effect of lysophosphatidic acid on the immune inflammatory response and the connexin 43 protein in myocardial infarction.

Authors:  Duoduo Zhang; Yan Zhang; Chunyan Zhao; Wenjie Zhang; Guoguang Shao; Hong Zhang
Journal:  Exp Ther Med       Date:  2016-03-09       Impact factor: 2.447

Review 4.  The connexin43 carboxyl terminus and cardiac gap junction organization.

Authors:  Joseph A Palatinus; J Matthew Rhett; Robert G Gourdie
Journal:  Biochim Biophys Acta       Date:  2011-08-09

5.  Enhanced PKCε mediated phosphorylation of connexin43 at serine 368 by a carboxyl-terminal mimetic peptide is dependent on injury.

Authors:  Joseph A Palatinus; Joshua M Rhett; Robert G Gourdie
Journal:  Channels (Austin)       Date:  2011-05-01       Impact factor: 2.581

6.  Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure.

Authors:  Suraj J Patel; Jack M Milwid; Kevin R King; Stefan Bohr; Arvin Iracheta-Vellve; Arvin Iracheta-Velle; Matthew Li; Antonia Vitalo; Biju Parekkadan; Rohit Jindal; Martin L Yarmush
Journal:  Nat Biotechnol       Date:  2012-01-15       Impact factor: 54.908

7.  Current and emerging antiarrhythmic drug therapy for ventricular tachycardia.

Authors:  Eric S Williams; Mohan N Viswanathan
Journal:  Cardiol Ther       Date:  2013-02-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.